Testosterone enanthate for eunuchism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Nov 2024: Trial registered, NCT06689085
  2. 7 Mar 2025: Trial started, NCT06689085

The trials

NCT06689085: 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

State
Under way
Phase
Phase 3
People
100 planned
Started
7 Mar 2025
Primary completion
Mar 2028
Arms
Participants
Results
None posted
  1. 14 Nov 2024: Trial registered
  2. 7 Mar 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as Delatestryl, Testosterone Enanthate 100 MG/ML Injectable Solution, Xyosted.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.